This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

QAD On Demand Life Sciences Edition Makes It Easier For Medtech To Address The Challenges Of Globalization

Stocks in this article: QADA QADB

QAD Inc. (NASDAQ:QADA) (NASDAQ:QADB) announced today it has seen increased deployments among Medical Technology ( Medtech) manufacturers for QAD On Demand Life Sciences Edition, the cloud enterprise resource planning (ERP) solution. QAD On Demand is full-strength cloud ERP that makes it easier for Medtech to meet globalization challenges and allocate capital for business initiatives and product innovation.

“Globalization has transformed demand for medical technology, accelerated production processes and given rise to new economies,” said Dave Medina, vice president of Life Sciences at QAD. “To meet today’s globalization challenges and opportunities, Medtech manufacturers are moving to the QAD global cloud ERP to benefit from its simplicity, reliability, global capabilities and predictable cost structure.”

QAD Cloud ERP Lets Medtech Focus on their Business and Product Innovation

QAD On Demand Life Sciences Edition offers the full suite of ERP capabilities and specific life sciences services to help QAD customers meet regulatory compliance. QAD cloud ERP allows Medtech manufacturers to focus on their business initiatives and product innovation – not their ERP software. The QAD cloud ERP model enables customers to eliminate capital expenditures associated with premise-based ERP software, hardware, system maintenance and support. QAD On Demand offers a robust and highly available solution. It is particularly scalable – and allows companies to standardize their ERP as they acquire new divisions, divest or pursue opportunities to rapidly scale operations in growth markets. QAD global capabilities with built-in support for local languages, currencies, business practices and legal requirements, enable Medtech manufacturers to efficiently align their global operations to strategic goals and perform at their best.

QAD Fully Qualified Cloud ERP – Built For Medical Technology Manufacturers

With QAD’s fully qualified IT environment and validation support tools, Medtech manufacturers can reduce the costs and effort of complying with regulatory requirements for software validation. QAD Life Science On Demand offers all the robust capabilities of QAD On Demand, but provides the necessary standard operating procedures (SOPs) required to meet requirements of the Food and Drug Administration (FDA), current Good Manufacturing Practices (cGMP) and 21 CFR Part 11.

Enhanced quality control capabilities in the QAD solution enhance product integrity across the global supply network -- from sourcing raw materials to distributing finished products -- with backward and forward traceability. This is particularly important for achieving regulatory requirements such as the emerging requirements for Unique Device Identification (UDI) compliance.

1 of 4

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs